GlassScriptPhysician profile
Reut Bardach
NPI 1780950527
$75,849.36
in general payments reported to CMS, 2019-2025
41 companies · $407 in 2025
The $407 reported for 2025 was more than what 75% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14K · 2020: $34K · 2021: $23K · 2022: $2,312 · 2023: $1,039 · 2024: $854 · 2025: $407.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,188 · Education: $112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,187.52 |
| Education | $112.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $69,027.91 | 2019-2024 | Da Vinci Surgical System |
| Abbvie INC. | $1,322.84 | 2019-2024 | Lo Loestrin Fe, Orilissa, Liletta |
| Astellas Pharma US INC | $757.46 | 2021-2025 | Veozah, Myrbetriq |
| Axonics, INC. | $755.52 | 2021-2023 | Axonics |
| Gynesonics, INC. | $313.77 | 2022 | |
| Exeltis, USA INC. | $312.94 | 2020-2025 | Slynd |
| Pfizer INC. | $255.51 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $236.34 | 2023-2024 | Myfembree |
| Roche Diagnostics Corporation | $214.66 | 2019-2021 | |
| Coopersurgical, INC. | $194.51 | 2019-2025 | Mara Console, Paragard T 380a, Ally II Ups |
| Therapeuticsmd, INC. | $193.61 | 2019-2021 | |
| Mayne Pharma Commercial LLC | $188.04 | 2021-2024 | |
| Merz North America, INC. | $183.12 | 2019 | |
| Myovant Sciences INC. | $173.96 | 2021-2022 | |
| Hologic Sales and Service, LLC | $162.78 | 2019-2025 | Aptima, Thinprep 2000 Processor, Novasure |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reut Bardach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.